[1]鲁世金,孙长英.免疫衰老对骨代谢及骨源性激素分泌的影响研究进展[J].新乡医学院学报,2019,36(9):896-900.[doi:10.7683/xxyxyxb.2019.09.022]

点击复制

免疫衰老对骨代谢及骨源性激素分泌的影响研究进展

分享到：

参考文献/References:

［1］　SALMINEN A，KAARNIRANTA K，KAUPPINEN A.Immunose-nescence：the potential role of myeloid-derived suppressor cells（MDSC）in age-related immune deficiency［J］.Cell Mol Life Sci，2019，76（10）：1901-1918.
［2］　HORVATHOVA M，ILAVSKA S，STEFIKOVA K，et al.The cell surface markers expression in postmenopausal women and relation to obesity and bone status［J］.Int J Environ Res Public Health，2017，14（7）：E751.
［3］　FOUGERE B，BOULANGER E，NOURHASHEMI F，et al.Chronic inflammation：accelerator of biological aging［J］.J Gerontol A Biol Sci Med Sci，2017，72（9）：1218-1225.
［4］　BAYLIS D，BARTLETT D B，PATEL H P，et al.Understanding how we age：insights into inflammaging［J］.Longev Healthspan，2013，2（1）：8.
［5］　ISEME R A，MCEVOY M，KELLY B，et al.Is osteoporosis an autoimmune mediated disorder［J］.Bone Rep，2017，7：121-131.
［6］　WEITZMANN M N.Bone and the immune system［J］.Toxicol Pathol，2017，45（7）：911-924.
［7］　WANG Y W，XU D P，LIU Y，et al.The effect of tumor necrosis factor-alpha at different concentrations on osteogenetic differentiation of bone marrow mesenchymal stem cells［J］.J Craniofac Surg，2015，26（7）：2081-2085.
［8］　ZHAO B.Does TNF promote or restrain osteoclastogenesis and inflammatory bone resorption［J］.Crit Rev Immunol，2018，38（4）：253-261.
［9］　KIM B J，BAE S J，LEE S Y，et al.TNF-alpha mediates the stimulation of sclerostin expression in an estrogen-deficient condition［J］.Biochem Biophys Res Commun，2012，424（1）：170-175.
［10］　VAN DINTHER M，ZHANG J，WEIDAUER S E，et al.Anti-Sclerostin antibody inhibits internalization of Sclerostin and Sclerostin-mediated antagonism of Wnt/LRP6 signaling［J］.PLoS One，2013，8（4）：1-11.
［11］　TSAI C N，TSAI C L，YI J S，et al.Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells［J］.Sci Rep，2019，9（1）：5197.
［12］　MOSIALOU I，SHIKHEL S，LIU J M，et al.MC4R-dependent suppression of appetite by bone-derived lipocalin 2［J］.Nature，2018，543（7645）：385-390.
［13］　ZHANG L，GAN X，HE Y，et al.Drp1-dependent mitochondrial fission mediates osteogenic dysfunction in inflammation through elevated production of reactive oxygen species［J］.PLoS One，2017，12（4）：e0175262.
［14］　HARMER D，FALANK C，REAGAN M R.Interleukin-6 interwea-ves the bone marrow microenvironment，bone loss，and multiple myeloma［J］.Front Endocrinol（Lausanne），2019，9：788.
［15］　于超平，姚建晗，高原，等.白细胞介素-6 与骨质疏松相关研究进展［J］.新乡医学院学报，2017，34（11）：1040-1042.
［16］　MOULTON V R.Sex hormones in acquired immunity and autoi-mmune disease［J］.Front Immunol，2018，9：2279.
［17］　PONZETTI M，RUCCI N.Updates on osteoimmunology：what′s new on the cross-talk between bone and immune system［J］.Front Endocrinol（Lausanne），2019，10：236.
［18］　ALVES A S，BUENO V.Immunosenescence：participation of T lymphocytes and myeloid-derived suppressor cells in aging-related immune response changes［J］.Einstein（Sao Paulo），2019，17（2）：1-5.
［19］　ZHAN Y，CHOW K V，SOO P，et al.Plasmacytoid dendritic cells are short-lived：reappraising the influence of migration，genetic factors and activation on estimation of lifespan plasmacytoid dendritic cells are short-lived：reappraising the influence of migration，genetic factors and activation on estimation of lifespan［J］.Sci Rep，2016，6：25060.
［20］　TILKERIDIS K，KIZIRIDIS G，VERVERIDIS A，et al.Immunopo-rosis：a new role for invariant natural killer T（NKT）cells through overexpression of nuclear factor-kappaB ligand（RANKL）［J］.Med Sci Monit，2019，25：2151-2158.
［21］　YANG D H，YANG M Y.The Role of Macrophage in the patho-genesis of osteoporosis［J］.Int J Mol Sci，2019，20（9）：1-15.
［22］　陶鹏辉.强直性脊柱炎患者血清非磷酸化基质γ-羧基谷氨酸蛋白和巨噬细胞集落刺激因子水平与骨代谢生物化学指标的相关性［J］.新乡医学院学报，2017，34（7）：627-629.
［23］　METZGER C E，NARAYANAN S A.The role of osteocytes in inflammatory bone Loss［J］.Front Endocrinol（Lausanne），2019，10：285.
［25］　KOMATSU N，TAKAYANAGI H.Immune-bone interplay in the structural damage in rheumatoid arthritis［J］.Clin Exp Immunol，2018，194（1）：1-8.
［26］　GINALDI L，DE MARTINIS M，SAITTA S，et al.Interleukin-33 serum levels in postmenopausal women with osteoporosis［J］.Sci Rep，2019，9（1）：3786.
［27］　SOBACCHI C，MENALE C，VILLA A.The RANKL-RANK axis：a bone to thymus round trip［J］.Front Immunol，2019，10：629.
［28］　MADEL M B，IBANEZ L，WAKKACH A，et al.Immune function and diversity of osteoclasts in normal and pathological conditions［J］.Front Immunol，2019，10：1408.
［29］　PANACH L，PINEDA B，MIFSUT D，et al.The role of CD40 and CD40L in bone mineral density and in osteoporosis risk：a genetic and functional study［J］.Bone，2016，83：94-103.
［30］　ROBINSON J W，LI J Y，WALKER L D，et al.T cell-expressed CD40L potentiates the bone anabolic activity of intermittent PTH treatment［J］.J Bone Miner Res，2015，30（4）：695-705.
［31］　KRISHNAMURTHY A，YTTERBERG A J，SUN M，et al.Citru-llination controls dendritic cell transdifferentiation into osteoclasts［J］.J Immunol，2019，202（11）：3143-3150.
［32］　WYTHE S E，NICOLAIDOU V，HORWOOD N J.Cells of the immune system orchestrate changes in bone cell function［J］.Calcif Tissue Int，2014，94（1）：98-111.
［33］　HAJISHENGALLIS G，MOUTSOPOULOS N M，HAJISHEN-GALLIS E，et al.Immune and regulatory functions of neutrophils in inflammatory bone loss［J］.Semin Immunol，2016，28（2）：146-158.
［34］　MORTAZ E，ALIPOOR S D，ADCOCK I M，et al.Update on neutrophil function in severe inflammation［J］.Front Immunol，2018，9：1-14.
［35］　JEZEK J，COOPER K F，STRICH R.Reactive oxygen species and mitochondrial dynamics：the yin and yang of mitochondrial dysfunction and cancer progression［J］.Antioxidants（Basel），2018，7（1）：1-24.
［36］　BRATIC I，TRIFUNOVIC A.Mitochondrial energy metabolism and ageing［J］.Biochim Biophys Acta，2010，1797（6/7）：961-967.
［37］　YONESHIMA E，OKAMOTO K，SAKAI E，et al.The transcription factor EB（TFEB）regulates osteoblast differentiation through ATF4/CHOP-dependent pathway［J］.J Cell Physiol，2016，231（6）：1321-1333.
［38］　CHARLES J F，ALIPRANTIS A O.Osteoclasts：more than "bone eaters"［J］.Trends Mol Med，2014，20（8）：449-459.
［39］　KIM B J，LEE Y S，LEE S Y，et al.Osteoclast-secreted SLIT3 coordinates bone resorption and formation［J］.J Clin Invest，2018，128（4）：1429-1441.
［40］　KOH J M.Osteoclast-derived SLIT3 is a coupling factor linking bone resorption to bone formation［J］.BMB Rep，2018，51（6）：263-264.
［41］　SIMS N A，MARTIN T J.Coupling signals between the osteoclast and osteoblast：how are messages transmitted between these temporary visitors to the bone surface［J］.Front Endocrinol（Lausanne），2015，6：41.
［42］　FUKUMOTO S，MARTIN T J.Bone as an endocrine organ［J］.Trends Endocrinol Metab，2009，20（5）：230-236.
［43］　PAN J M，WU L G，CAI J W，et al.Dexamethasone suppresses osteogenesis of osteoblast via the PI3K/Akt signaling pathway in vitro and in vivo［J］.J Recept Signal Transduct Res，2019，39（1）：80-86.
［44］　COSTA D，PRINCIPI E，LAZZARINI E，et al.LCN2 overexpression in bone enhances the hematopoietic compartment via modulation of the bone marrow microenvironment［J］.J Cell Physiol，2017，232（11）：3077-3087.
［45］　TAKASHI Y，FUKUMOTO S，MATSUMOTO T.Bone-derived hormones and their systemic regulation［J］.Clin Calcium，2019，28（1）：9-15.
［46］　MERA P，FERRON M，MOSIALOU I.Regulation of energy meta-bolism by bone-derived hormones［J］.Cold Spring Harb Perspect Med，2018，8（6）：1-15.
［47］　FITZPATRICK E A，HAN X，XIAO Z，et al.Role of fibroblast growth factor-23 in innate immune responses［J］.Front Endocrinol（Lausanne），2018，9：320.
［48］　TAKASHI Y，FUKUMOTO S，MATSUMOTO T.Bone-derived hormones and their systemic regulation［J］.Clin Calcium，2018，28（1）：9-15.
［49］　CHEN G，LIU Y，GOETZ R，et al.α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling［J］.Nature，2018，553（7689）：461-466.